Earnings Call · Q4 FY2022·2023-02-09

Q4 22EPS +0.56%·Rev n/aQ3 22EPS +2.52%·Rev n/aQ2 22EPS +1.81%·Rev n/aQ1 22EPS +0.64%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Senior Vice President, Investor Relations

Rick Gonzalez — Chairman of the Board and Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Carrie Strom — Senior Vice President and President, Allergan Aesthetics

Tom Hudson — Senior Vice President, R&D, Chief Scientific Officer

Rob Michael — Vice Chairman and President

+2.8%1d on move date+3.7% vs SPY3d+6.3%5d+4.5%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access